Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Triple Negative Breast Cancer
Interventions: DRUG: SZ011 CAR-NK
Sponsor: First Affiliated Hospital of Shantou University Medical College
Collaborators: Guangdong ProCapZoom Biosciences Co., Ltd.